{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:46:57Z","timestamp":1782899217124,"version":"3.54.5"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhenjiang Science and Technology Plan\u2014Social Development Project","award":["SH2024035, SH2024064"],"award-info":[{"award-number":["SH2024035, SH2024064"]}]},{"name":"Zhenjiang Science and Technology Plan\u2014Social Development Project","award":["SH2024035, SH2024064"],"award-info":[{"award-number":["SH2024035, SH2024064"]}]},{"name":"Zhenjiang Science and Technology Plan\u2014Social Development Project","award":["SH2024035, SH2024064"],"award-info":[{"award-number":["SH2024035, SH2024064"]}]},{"name":"Zhenjiang Science and Technology Plan\u2014Social Development Project","award":["SH2024035, SH2024064"],"award-info":[{"award-number":["SH2024035, SH2024064"]}]},{"name":"Zhenjiang Science and Technology Plan\u2014Social Development Project","award":["SH2024035, SH2024064"],"award-info":[{"award-number":["SH2024035, SH2024064"]}]},{"name":"Zhenjiang Science and Technology Plan\u2014Social Development Project","award":["SH2024035, SH2024064"],"award-info":[{"award-number":["SH2024035, SH2024064"]}]},{"name":"Affiliated Hospital of Jiangsu University \"5123\" Talent Program Outstanding Discipline Leader Training Fund","award":["51232017104"],"award-info":[{"award-number":["51232017104"]}]},{"name":"Affiliated Hospital of Jiangsu University \"5123\" Talent Program Outstanding Discipline Leader Training Fund","award":["51232017104"],"award-info":[{"award-number":["51232017104"]}]},{"name":"Affiliated Hospital of Jiangsu University \"5123\" Talent Program Outstanding Discipline Leader Training Fund","award":["51232017104"],"award-info":[{"award-number":["51232017104"]}]},{"name":"Affiliated Hospital of Jiangsu University \"5123\" Talent Program Outstanding Discipline Leader Training Fund","award":["51232017104"],"award-info":[{"award-number":["51232017104"]}]},{"name":"Affiliated Hospital of Jiangsu University \"5123\" Talent Program Outstanding Discipline Leader Training Fund","award":["51232017104"],"award-info":[{"award-number":["51232017104"]}]},{"name":"Affiliated Hospital of Jiangsu University \"5123\" Talent Program Outstanding Discipline Leader Training Fund","award":["51232017104"],"award-info":[{"award-number":["51232017104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03186-2","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:03:58Z","timestamp":1778220238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic hepatitis B virus infection and the risk of extrahepatic malignancies: an updated review of epidemiology, mechanisms, and clinical implications"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhongda","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"5","key":"3186_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/gutjnl-2017-314904","volume":"67","author":"G-A Kim","year":"2018","unstructured":"Kim G-A, Lim Y-S, Han S, Choi J, Shim JH, Kim KM, et al. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B. Gut. 2018;67(5):945\u201352.","journal-title":"Gut"},{"issue":"29","key":"3186_CR2","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1200\/JCO.21.01285","volume":"40","author":"DH Lee","year":"2022","unstructured":"Lee DH, Chung SW, Lee J-H, Kim HY, Chung GE, Kim M-S, et al. Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study. J Clin Oncol. 2022;40(29):3394\u2013405.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3186_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/jmv.23754","volume":"86","author":"K Sundquist","year":"2014","unstructured":"Sundquist K, Sundquist J, Ji J. Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden. J Med Virol. 2014;86(1):18\u201322.","journal-title":"J Med Virol"},{"key":"3186_CR4","doi-asserted-by":"publisher","first-page":"1141956","DOI":"10.3389\/fimmu.2023.1141956","volume":"14","author":"Y Min","year":"2023","unstructured":"Min Y, Wei X, Xia X, Wei Z, Li R, Jin J, et al. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Front Immunol. 2023;14:1141956.","journal-title":"Front Immunol"},{"key":"3186_CR5","doi-asserted-by":"publisher","first-page":"104003","DOI":"10.1016\/j.ebiom.2022.104003","volume":"79","author":"AB Kamiza","year":"2022","unstructured":"Kamiza AB, Fatumo S, Singini MG, Yeh C-C, Chikowore T. Hepatitis B infection is causally associated with extrahepatic cancers: A Mendelian randomization study. EBioMedicine. 2022;79:104003.","journal-title":"EBioMedicine"},{"issue":"11","key":"3186_CR6","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3390\/jcm10112395","volume":"10","author":"Y-Y Chu","year":"2021","unstructured":"Chu Y-Y, Cheng J-S, Wu T-S, Chen C-W, Chang M-Y, Ku H-P, et al. Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study. J Clin Med. 2021;10(11):2395.","journal-title":"J Clin Med"},{"issue":"9","key":"3186_CR7","doi-asserted-by":"publisher","first-page":"e0237515","DOI":"10.1371\/journal.pone.0237515","volume":"15","author":"R Herrero","year":"2020","unstructured":"Herrero R, Heise K, Acevedo J, Cook P, Gonzalez C, Gahona J, et al. Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile. PLoS ONE. 2020;15(9):e0237515.","journal-title":"PLoS ONE"},{"issue":"1","key":"3186_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13027-022-00466-8","volume":"17","author":"C Luo","year":"2022","unstructured":"Luo C, Yu S, Zhang J, Wu X, Dou Z, Li Z, et al. Hepatitis B or C viral infection and the risk of cervical cancer. Infect Agent Cancer. 2022;17(1):54.","journal-title":"Infect Agent Cancer"},{"issue":"9","key":"3186_CR9","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.14309\/ajg.0000000000000651","volume":"115","author":"JK Lim","year":"2020","unstructured":"Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Prevalence of Chronic Hepatitis B Virus Infection in the United States. Am J Gastroenterol. 2020;115(9):1429\u201338.","journal-title":"Am J Gastroenterol"},{"key":"3186_CR10","unstructured":"Hou J, Liu Z, Fau - Gu F, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. (1449\u20131907 (Electronic))."},{"issue":"5 Suppl","key":"3186_CR11","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1002\/hep.22975","volume":"49","author":"WR Kim","year":"2009","unstructured":"Kim WR. Epidemiology of hepatitis B in the United States. Hepatology. 2009;49(5 Suppl):S28\u201334.","journal-title":"Hepatology"},{"key":"3186_CR12","doi-asserted-by":"publisher","first-page":"139696","DOI":"10.1016\/j.scitotenv.2020.139696","volume":"740","author":"C Hou","year":"2020","unstructured":"Hou C, Hua Z, Xu P, Xu H, Wang Y, Liao J, et al. Estimating the prevalence of hepatitis B by wastewater-based epidemiology in 19 cities in China. Sci Total Environ. 2020;740:139696.","journal-title":"Sci Total Environ"},{"issue":"10161","key":"3186_CR13","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","volume":"392","author":"W-K Seto","year":"2018","unstructured":"Seto W-K, Lo Y-R, Pawlotsky J-M, Yuen M-F. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313\u201324.","journal-title":"Lancet"},{"issue":"5","key":"3186_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","volume":"151","author":"WS Mason","year":"2016","unstructured":"Mason WS, Gill US, Litwin S, Zhou Y, Peri S, Pop O, et al. HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant. Gastroenterology. 2016;151(5):986\u201398.e4.","journal-title":"Gastroenterology"},{"key":"3186_CR15","doi-asserted-by":"publisher","first-page":"1518567","DOI":"10.3389\/fonc.2024.1518567","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang C, Chen L, Xiu Y, Zhang H, Zhang Y, Ying W. Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021. Front Oncol. 2024;14:1518567.","journal-title":"Front Oncol"},{"issue":"3","key":"3186_CR16","doi-asserted-by":"publisher","first-page":"e90438","DOI":"10.1371\/journal.pone.0090438","volume":"9","author":"F-F Shen","year":"2014","unstructured":"Shen F-F, Yue W-B, Zhou F-Y, Pan Y, Zhao X-K, Jin Y, et al. Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China. PLoS ONE. 2014;9(3):e90438.","journal-title":"PLoS ONE"},{"issue":"7","key":"3186_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/bjc.2014.406","volume":"112","author":"XL Wei","year":"2015","unstructured":"Wei XL, Qiu MZ, Jin Y, Huang YX, Wang RY, Chen WW, et al. Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases. Br J Cancer. 2015;112(7):1283\u201390.","journal-title":"Br J Cancer"},{"issue":"1","key":"3186_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jmv.25584","volume":"92","author":"H Cui","year":"2020","unstructured":"Cui H, Jin Y, Chen F, Ni H, Hu C, Xu Y, et al. Clinicopathological evidence of hepatitis B virus infection in the development of gastric adenocarcinoma. J Med Virol. 2020;92(1):71\u20137.","journal-title":"J Med Virol"},{"issue":"2","key":"3186_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12029-016-9809-5","volume":"47","author":"KA Lowe","year":"2016","unstructured":"Lowe KA, Danese MD, Gleeson ML, Langeberg WJ, Ke J, Kelsh MA. Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States. J Gastrointest Cancer. 2016;47(2):168\u201381.","journal-title":"J Gastrointest Cancer"},{"issue":"2","key":"3186_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4143\/crt.2018.146","volume":"51","author":"Q Yao","year":"2019","unstructured":"Yao Q, Qi X, Cheng W, Xie S-H. A Comprehensive Assessment of the Racial and Ethnic Disparities in the Incidence of Gastric Cancer in the United States, 1992\u20132014. Cancer Res Treat. 2019;51(2):519\u201329.","journal-title":"Cancer Res Treat"},{"issue":"12","key":"3186_CR21","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.dld.2015.09.001","volume":"47","author":"S Mancini","year":"2015","unstructured":"Mancini S, Ravaioli A, Giuliani O, Giorgetti S, Falcini F, Colamartini A, et al. Gastric cancer incidence in the Romagna Region of Italy: A spatial and temporal analysis. Dig Liver Dis. 2015;47(12):1076\u201381.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"3186_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13027-025-00648-0","volume":"20","author":"D Chen","year":"2025","unstructured":"Chen D, Yu R, Cai Y, Zhang H, Jiang Y, Wu Y, et al. Additive interaction between hepatitis B virus infection and tobacco smoking on the risk of gastric cancer in a Chinese population. Infect Agent Cancer. 2025;20(1):19.","journal-title":"Infect Agent Cancer"},{"issue":"8","key":"3186_CR23","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00432-012-1210-6","volume":"138","author":"D Shi","year":"2012","unstructured":"Shi D, Wang S, Gu D, Wu D, Wang M, Chu H, et al. The PSCA polymorphisms derived from genome-wide association study are associated with risk of gastric cancer: a meta-analysis. J Cancer Res Clin Oncol. 2012;138(8):1339\u201345.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"3186_CR24","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3390\/jcm8122085","volume":"8","author":"YS Jung","year":"2019","unstructured":"Jung YS, Kim NH, Park JH, Park DI, Sohn CI. Correlation between Hepatitis B Virus Infection and Colorectal Neoplasia. J Clin Med. 2019;8(12):2085.","journal-title":"J Clin Med"},{"issue":"6","key":"3186_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3748\/wjg.v17.i6.804","volume":"17","author":"H-B Qiu","year":"2011","unstructured":"Qiu H-B, Zhang L-Y, Zeng Z-L, Wang Z-Q, Luo H-Y, Keshari RP, et al. HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study. World J Gastroenterol. 2011;17(6):804\u20138.","journal-title":"World J Gastroenterol"},{"key":"3186_CR26","doi-asserted-by":"crossref","unstructured":"Le C, Liu C, Lu B, Zhou X, Jiamaliding Y, Jin T et al. Association between Hepatitis B virus infection and liver metastasis in colorectal cancer. MedComm (2020). 2024;5(7):e584.","DOI":"10.1002\/mco2.584"},{"issue":"2","key":"3186_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.amjms.2018.04.016","volume":"356","author":"SH Kim","year":"2018","unstructured":"Kim SH, Kim JW, Lee KL, Lee S, Koh S-J, Jeong JB, et al. Hepatitis B Virus Infection Is Independently Associated With Advanced Colorectal Adenoma. Am J Med Sci. 2018;356(2):141\u20136.","journal-title":"Am J Med Sci"},{"issue":"3","key":"3186_CR28","first-page":"529","volume":"24","author":"G Luo","year":"2013","unstructured":"Luo G, Hao N-B, Hu C-J, Yong X, L\u00fc M-H, Cheng B-J, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes Control. 2013;24(3):529\u201337.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"3186_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/00365521.2020.1868568","volume":"56","author":"X Liu","year":"2021","unstructured":"Liu X, Zhang Z-H, Jiang F. Hepatitis B virus infection increases the risk of pancreatic cancer: a meta-analysis. Scand J Gastroenterol. 2021;56(3):252\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"3186_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1478-3231.2009.02147.x","volume":"30","author":"UH Iloeje","year":"2010","unstructured":"Iloeje UH, Yang H-I, Jen C-L, Su J, Wang L-Y, You S-L, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int. 2010;30(3):423\u20139.","journal-title":"Liver Int"},{"issue":"2","key":"3186_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ijc.26376","volume":"131","author":"D-S Wang","year":"2012","unstructured":"Wang D-S, Chen D-L, Ren C, Wang Z-Q, Qiu M-Z, Luo H-Y, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer. 2012;131(2):461\u20138.","journal-title":"Int J Cancer"},{"issue":"2","key":"3186_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.crohns.2012.03.001","volume":"7","author":"A Papa","year":"2013","unstructured":"Papa A, Felice C, Marzo M, Andrisani G, Armuzzi A, Covino M, et al. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-\u03b1 agents. J Crohns Colitis. 2013;7(2):113\u20139.","journal-title":"J Crohns Colitis"},{"issue":"23","key":"3186_CR33","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.3390\/cancers16233997","volume":"16","author":"C-H Su","year":"2024","unstructured":"Su C-H, Chen C-Y, Liu C-T, Yang Y-H, Wu P-C. Hepatitis and Hepatitis B Virus Reactivation in Everolimus-Treated Solid Tumor Patients: A Focus on HBV-Endemic Areas. Cancers (Basel). 2024;16(23):3997.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3186_CR34","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1053\/j.gastro.2017.07.001","volume":"153","author":"M-W Yu","year":"2017","unstructured":"Yu M-W, Lin C-L, Liu C-J, Yang S-H, Tseng Y-L, Wu C-F. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study. Gastroenterology. 2017;153(4):1006\u201317.e5.","journal-title":"Gastroenterology"},{"issue":"2\u20133","key":"3186_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","volume":"48","author":"G Rong","year":"2015","unstructured":"Rong G, Wang H, Bowlus CL, Wang C, Lu Y, Zeng Z, et al. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48(2\u20133):132\u201341.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"3186_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.gie.2018.07.033","volume":"89","author":"SS Thiruvengadam","year":"2019","unstructured":"Thiruvengadam SS, Lopez R, O\u2019Malley M, LaGuardia L, Church JM, Kalady M, et al. Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis. Gastrointest Endosc. 2019;89(2):345\u201354.e2.","journal-title":"Gastrointest Endosc"},{"key":"3186_CR37","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.2147\/CMAR.S198714","volume":"11","author":"Y Fu","year":"2019","unstructured":"Fu Y, Yang X, Liang H, Wu X. Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection. Cancer Manag Res. 2019;11:5091\u2013100.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3186_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-020-00915-0","volume":"13","author":"Y Deng","year":"2020","unstructured":"Deng Y, Zhao P, Zhou L, Xiang D, Hu J, Liu Y, et al. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study. J Hematol Oncol. 2020;13(1):98.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3186_CR39","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jtho.2021.03.030","volume":"16","author":"S Safiri","year":"2021","unstructured":"Safiri S, Sohrabi M-R, Carson-Chahhoud K, Bettampadi D, Taghizadieh A, Almasi-Hashiani A, et al. Burden of Tracheal, Bronchus, and Lung Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019. J Thorac Oncol. 2021;16(6):945\u201359.","journal-title":"J Thorac Oncol"},{"key":"3186_CR40","doi-asserted-by":"publisher","first-page":"104209","DOI":"10.1016\/j.jcv.2019.104209","volume":"121","author":"S Don\u00e0","year":"2019","unstructured":"Don\u00e0 S, Borsetto D, Fussey J, Biscaro V, Vian E, Spinato G, et al. Association between hepatitis C and B viruses and head and neck squamous cell carcinoma. J Clin Virol. 2019;121:104209.","journal-title":"J Clin Virol"},{"issue":"1","key":"3186_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12943-024-02188-4","volume":"23","author":"J Huang","year":"2024","unstructured":"Huang J, Chen M, Zhang L, Lin X, Lucero-Prisno DE, Zhong CC, et al. Incidence, risk factors, and epidemiological trends of tracheal cancer: a global analysis. Mol Cancer. 2024;23(1):271.","journal-title":"Mol Cancer"},{"issue":"1","key":"3186_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13690-024-01333-1","volume":"82","author":"SE Mousavi","year":"2024","unstructured":"Mousavi SE, Ilaghi M, Aslani A, Najafi M, Yekta Z, Nejadghaderi SA. Laryngeal cancer incidence trends in the United States over 2000\u20132020: a population-based analysis. Arch Public Health. 2024;82(1):106.","journal-title":"Arch Public Health"},{"key":"3186_CR43","doi-asserted-by":"publisher","first-page":"107327482110412","DOI":"10.1177\/10732748211041236","volume":"28","author":"H Qi","year":"2021","unstructured":"Qi H, Chen W, Zhang C, Zheng X, Peng C, Zhao Q, et al. Epidemiological Analysis of 1234 Cases of Laryngeal Cancer in Shanxi Province, China. Cancer Control. 2021;28:10732748211041236.","journal-title":"Cancer Control"},{"issue":"12","key":"3186_CR44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12094-012-0879-y","volume":"14","author":"H Gong","year":"2012","unstructured":"Gong H, Shi Y, Zhou L, Tao L, Shi Y, Cao W, et al. Helicobacter pylori infection of the larynx may be an emerging risk factor for laryngeal squamous cell carcinoma. Clin Transl Oncol. 2012;14(12):905\u201310.","journal-title":"Clin Transl Oncol"},{"key":"3186_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.12659\/MSM.893084","volume":"21","author":"P-J Yu","year":"2015","unstructured":"Yu P-J, Chen W-G, Feng Q-L, Chen W, Jiang M-J, Li Z-Q. Association between CYP1B1 gene polymorphisms and risk factors and susceptibility to laryngeal cancer. Med Sci Monit. 2015;21:239\u201345.","journal-title":"Med Sci Monit"},{"issue":"1","key":"3186_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cncr.28377","volume":"120","author":"X Liu","year":"2014","unstructured":"Liu X, Li X, Jiang N, Lei Y, Tang L-L, Chen L, et al. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China. Cancer. 2014;120(1):68\u201376.","journal-title":"Cancer"},{"issue":"18","key":"3186_CR47","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1002\/cncr.30775","volume":"123","author":"J-W Lv","year":"2017","unstructured":"Lv J-W, Chen Y-P, Huang X-D, Zhou G-Q, Chen L, Li W-F, et al. Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area. Cancer. 2017;123(18):3540\u20139.","journal-title":"Cancer"},{"issue":"2","key":"3186_CR48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/cam4.2715","volume":"9","author":"J-J Weng","year":"2020","unstructured":"Weng J-J, Wei J-Z, Li M, Lu J-L, Qin Y-D, Jiang H, et al. Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma. Cancer Med. 2020;9(2):541\u201351.","journal-title":"Cancer Med"},{"key":"3186_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jcv.2014.11.024","volume":"64","author":"T Xu","year":"2015","unstructured":"Xu T, Huang Z, Deng Y, Wang S, Su B, Wei W, et al. Clinical implications of hepatitis B viral infection in Epstein-Barr virus-associated nasopharyngeal carcinoma. J Clin Virol. 2015;64:64\u201371.","journal-title":"J Clin Virol"},{"issue":"1","key":"3186_CR50","doi-asserted-by":"publisher","first-page":"262","DOI":"10.21037\/tcr.2019.01.25","volume":"8","author":"X Li","year":"2019","unstructured":"Li X, Wu W, Chen J, Ye W, Zhang J, Wei T. Effect of hepatitis B virus infection status on liver metastasis of nasopharyngeal carcinoma: a cohort study. Transl Cancer Res. 2019;8(1):262\u201372.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"3186_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12094-024-03578-2","volume":"27","author":"Z-X Li","year":"2025","unstructured":"Li Z-X, Huang J, Hu L, Jiang Z-Y, Ran L, Liang X-Y, et al. Cross-sectional study of hepatitis B virus infection in female breast cancer patients in China for the first time diagnosed. Clin Transl Oncol. 2025;27(1):257\u201364.","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"3186_CR52","doi-asserted-by":"publisher","first-page":"180","DOI":"10.21037\/atm.2020.01.97","volume":"8","author":"W Xiao","year":"2020","unstructured":"Xiao W, Zhou Y, Yu P, Yang A, Zheng S, Tang H, et al. Prognostic value of chronic hepatitis B virus infection in patients with breast cancer in a hepatitis B virus endemic area. Ann Transl Med. 2020;8(5):180.","journal-title":"Ann Transl Med"},{"issue":"4","key":"3186_CR53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/bjc.2011.4","volume":"104","author":"J Yun","year":"2011","unstructured":"Yun J, Kim KH, Kang ES, Gwak GY, Choi MS, Lee JE, et al. Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy. Br J Cancer. 2011;104(4):559\u201363.","journal-title":"Br J Cancer"},{"issue":"1","key":"3186_CR54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/infdis\/jir710","volume":"205","author":"J-R He","year":"2012","unstructured":"He J-R, Chen L-J, Su Y, Cen Y-L, Tang L-Y, Yu D-D, et al. Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-\u03b3 on breast cancer risk. J Infect Dis. 2012;205(1):64\u201371.","journal-title":"J Infect Dis"},{"issue":"5","key":"3186_CR55","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/jvh.13250","volume":"27","author":"L Wong","year":"2020","unstructured":"Wong L, Cheung TH, Yim SF, Lao TT. Prevalence and impact of hepatitis B virus infection in ovarian cancer patients in an endemic area-A retrospective cohort study. J Viral Hepat. 2020;27(5):520\u20135.","journal-title":"J Viral Hepat"},{"issue":"3","key":"3186_CR56","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00277-023-05554-2","volume":"103","author":"C-Y Shang","year":"2024","unstructured":"Shang C-Y, Bei L-Y, Wu J-Z, Sheng H-R, Yin H, Liang J-H, et al. NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia. Ann Hematol. 2024;103(3):833\u201341.","journal-title":"Ann Hematol"},{"issue":"2","key":"3186_CR57","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11033-011-0851-x","volume":"39","author":"M Mirzaee","year":"2012","unstructured":"Mirzaee M, Yaghobi R, Ramzi M, Roshan Nia M. The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies. Mol Biol Rep. 2012;39(2):1217\u201323.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"3186_CR58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00705-016-3111-5","volume":"162","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Zhang Y, Xu N, Huang C, Li X, Li J. High risk of occult hepatitis B virus infection in leukemia patients from China. Arch Virol. 2017;162(2):349\u201357.","journal-title":"Arch Virol"},{"issue":"1","key":"3186_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13027-021-00396-x","volume":"16","author":"D-G Chen","year":"2021","unstructured":"Chen D-G, Chen G, Wang C, Ke L-F, Wu H, He H-M, et al. Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China. Infect Agent Cancer. 2021;16(1):57.","journal-title":"Infect Agent Cancer"},{"issue":"12","key":"3186_CR60","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1007\/s00277-023-05412-1","volume":"102","author":"M Visentini","year":"2023","unstructured":"Visentini M, Pica A, D\u2019Ippolito G, Sculco E, La Gualana F, Gragnani L, et al. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy. Ann Hematol. 2023;102(12):3457\u201363.","journal-title":"Ann Hematol"},{"issue":"1","key":"3186_CR61","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12885-019-5718-x","volume":"19","author":"X Zhou","year":"2019","unstructured":"Zhou X, Pan H, Yang P, Ye P, Cao H, Zhou H. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma. BMC Cancer. 2019;19(1):477.","journal-title":"BMC Cancer"},{"issue":"9","key":"3186_CR62","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.leukres.2013.06.007","volume":"37","author":"S Dalia","year":"2013","unstructured":"Dalia S, Chavez J, Castillo JJ, Sokol L. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies. Leuk Res. 2013;37(9):1107\u201315.","journal-title":"Leuk Res"},{"issue":"3","key":"3186_CR63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00277-017-3188-2","volume":"97","author":"C Wang","year":"2018","unstructured":"Wang C, Xia B, Ning Q, Zhao H, Yang H, Zhao Z, et al. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin\u2019s lymphoma in China. Ann Hematol. 2018;97(3):453\u20137.","journal-title":"Ann Hematol"},{"issue":"2","key":"3186_CR64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/annonc\/mdr142","volume":"23","author":"DHT Mya","year":"2012","unstructured":"Mya DHT, Han ST, Linn YC, Hwang WYK, Goh YT, Tan DCL. Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection. Ann Oncol. 2012;23(2):421\u20136.","journal-title":"Ann Oncol"},{"issue":"3","key":"3186_CR65","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0366-6999.174508","volume":"129","author":"J Lu","year":"2016","unstructured":"Lu J, Chen W-M, Geng C-Y, Durie BG, Huang X-J. Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study. Chin Med J (Engl). 2016;129(3):274\u20138.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"3186_CR66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/10428194.2011.610013","volume":"53","author":"B Huang","year":"2012","unstructured":"Huang B, Li J, Zhou Z, Zheng D, Liu J, Chen M. High prevalence of hepatitis B virus infection in multiple myeloma. Leuk Lymphoma. 2012;53(2):270\u20134.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"3186_CR67","first-page":"6196","volume":"18","author":"D Guo","year":"2019","unstructured":"Guo D, Xu P, Guan C, Xu Y, Yang Y, Xu J, et al. Hepatitis B virus infection and 1q21 amplification in multiple myeloma. Oncol Lett. 2019;18(6):6196\u2013206.","journal-title":"Oncol Lett"},{"issue":"1","key":"3186_CR68","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s12879-020-05412-w","volume":"20","author":"C Lin","year":"2020","unstructured":"Lin C, Shen H, Zhou S, Liu M, Xu A, Huang S, et al. Assessment of infection in newly diagnosed multiple myeloma patients: risk factors and main characteristics. BMC Infect Dis. 2020;20(1):699.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"3186_CR69","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/jmv.23694","volume":"85","author":"T Matsui","year":"2013","unstructured":"Matsui T, Kang J-H, Nojima M, Tomonari A, Aoki H, Yamazaki H, et al. Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma. J Med Virol. 2013;85(11):1900\u20136.","journal-title":"J Med Virol"},{"issue":"11","key":"3186_CR70","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/cancers11111819","volume":"11","author":"Y Tsukune","year":"2019","unstructured":"Tsukune Y, Sasaki M, Komatsu N. Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma. Cancers (Basel). 2019;11(11):1819.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3186_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/17246008211056959","volume":"36","author":"H Wang","year":"2021","unstructured":"Wang H, Liu Y, Zhao Y. The association of hepatitis C virus infection and thyroid disease: A systematic review and meta-analysis. Int J Biol Markers. 2021;36(4):3\u20139.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"3186_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000453045","volume":"45","author":"Y-S Lin","year":"2017","unstructured":"Lin Y-S, Yeh C-C, Lin Y-C, Su C-T, Sung F-C, Chang S-N, et al. Kidney Cancer Linked to Chronic Hepatitis in the Asia-Pacific: A Population-Based Analysis. Am J Nephrol. 2017;45(1):22\u201331.","journal-title":"Am J Nephrol"},{"issue":"1","key":"3186_CR73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/TP.0000000000001870","volume":"102","author":"K Masutani","year":"2018","unstructured":"Masutani K, Omoto K, Okumi M, Okabe Y, Shimizu T, Tsuruya K, et al. Incidence of Hepatitis B Viral Reactivation After Kidney Transplantation With Low-Dose Rituximab Administration. Transplantation. 2018;102(1):140\u20135.","journal-title":"Transplantation"},{"issue":"7","key":"3186_CR74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"W-K Sung","year":"2012","unstructured":"Sung W-K, Zheng H, Li S, Chen R, Liu X, Li Y, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44(7):765\u20139.","journal-title":"Nat Genet"},{"key":"3186_CR75","doi-asserted-by":"publisher","first-page":"1506526","DOI":"10.3389\/fimmu.2025.1506526","volume":"16","author":"H Zheng","year":"2025","unstructured":"Zheng H, Xu B, Fan Y, Tuekprakhon A, Stamataki Z, Wang F. The role of immune regulation in HBV infection and hepatocellular carcinogenesis. Front Immunol. 2025;16:1506526.","journal-title":"Front Immunol"},{"issue":"3","key":"3186_CR76","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/sji.12524","volume":"85","author":"N Trehanpati","year":"2017","unstructured":"Trehanpati N, Vyas AK. Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer. Scand J Immunol. 2017;85(3):175\u201381.","journal-title":"Scand J Immunol"},{"key":"3186_CR77","doi-asserted-by":"publisher","first-page":"1320414","DOI":"10.3389\/fimmu.2023.1320414","volume":"14","author":"Q Bai","year":"2023","unstructured":"Bai Q, Li R, He X, Hong X, Yan Y, Zhao Z, et al. Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma. Front Immunol. 2023;14:1320414.","journal-title":"Front Immunol"},{"issue":"5","key":"3186_CR78","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/hep.30233","volume":"69","author":"J Choi","year":"2019","unstructured":"Choi J, Kim G-A, Han S, Lee W, Chun S, Lim Y-S. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma. Hepatology. 2019;69(5):1983\u201394.","journal-title":"Hepatology"},{"issue":"6","key":"3186_CR79","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/liv.13356","volume":"37","author":"H-T Zhu","year":"2017","unstructured":"Zhu H-T, Liu R-B, Liang Y-Y, Hasan AME, Wang H-Y, Shao Q, et al. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Liver Int. 2017;37(6):888\u201396.","journal-title":"Liver Int"},{"issue":"1","key":"3186_CR80","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000339018","volume":"1","author":"JM Lee","year":"2012","unstructured":"Lee JM, Yoon J-H, Joo I, Woo HS. Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma. Liver Cancer. 2012;1(1):22\u201340.","journal-title":"Liver Cancer"},{"issue":"23","key":"3186_CR81","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.3748\/wjg.v18.i23.2979","volume":"18","author":"JE Lee","year":"2012","unstructured":"Lee JE, Jang JY, Jeong SW, Lee SH, Kim SG, Cha S-W, et al. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography\/computed tomography scan. World J Gastroenterol. 2012;18(23):2979\u201387.","journal-title":"World J Gastroenterol"},{"key":"3186_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jcm11216247","volume":"11","author":"C Mazzaro","year":"2022","unstructured":"Mazzaro C, Adinolfi LE, Pozzato G, Nevola R, Zanier A, Serraino D, et al. Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy. J Clin Med. 2022;11:21.","journal-title":"J Clin Med"},{"issue":"7","key":"3186_CR83","doi-asserted-by":"publisher","first-page":"e102051","DOI":"10.1371\/journal.pone.0102051","volume":"9","author":"Y-C Yeh","year":"2014","unstructured":"Yeh Y-C, Liu C-J, Kuo RN, Lai C-L, Shau W-Y, Chen P-J, et al. Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort study. PLoS ONE. 2014;9(7):e102051.","journal-title":"PLoS ONE"},{"issue":"3","key":"3186_CR84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2021;19(3):151\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"3186_CR85","doi-asserted-by":"publisher","first-page":"113564","DOI":"10.1016\/j.ejca.2024.113564","volume":"199","author":"BH Ten Haaft","year":"2024","unstructured":"Ten Haaft BH, Pedregal M, Prato J, Kl\u00fcmpen H-J, Moreno V, Lamarca A. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives. Eur J Cancer. 2024;199:113564.","journal-title":"Eur J Cancer"},{"issue":"14","key":"3186_CR86","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.21.02112","volume":"40","author":"S Li","year":"2022","unstructured":"Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, et al. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. J Clin Oncol. 2022;40(14):1529\u201341.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3186_CR87","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.3390\/ijms22105170","volume":"22","author":"S-Y Liu","year":"2021","unstructured":"Liu S-Y, Tsai IT, Hsu Y-C. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci. 2021;22(10):5170.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3186_CR88","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/ijms20112754","volume":"20","author":"C Boni","year":"2019","unstructured":"Boni C, Barili V, Acerbi G, Rossi M, Vecchi A, Laccabue D, et al. HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications. Int J Mol Sci. 2019;20(11):2754.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3186_CR89","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1097\/HEP.0000000000001260","volume":"82","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, Duangsonk K, Chen VL, Saokhieo P, Dejvajara D, Sukphutanan B, et al. Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021. Hepatology. 2025;82(5):1274\u201386.","journal-title":"Hepatology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03186-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:55:28Z","timestamp":1782896128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03186-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3186"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03186-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}